GoldBamboo.com - Knowledge is strong medicine
  

Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives with Type II Diabetes - Article


  Not Signed In - Sign In / Register


Get Your Free Credit Report Right Now!

Zip Code:



General Topics A-Z

Enalapril and Felodipine

Lexxel 



Clinical Trial: Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives with Type II Diabetes

This study is currently recruiting patients.
Verified by Solvay Pharmaceuticals September 2005

Sponsored by: Solvay Pharmaceuticals
Information provided by: Solvay Pharmaceuticals
ClinicalTrials.gov Identifier: NCT00160160

Purpose

This study is to demonstrate the superiority of combination of eprosartan /HCTZ versus ramipril/HCTZ
Condition Intervention
hypertension, type 2 diabetes
  Drug: eprosartan/HCTZ

MedlinePlus consumer health information 

Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Efficacy Study

Official Title: A Multi-Center, Double-Blind, Randomized Study Comparing the Efficacy of Combination Therapy of Eprosartan Respectively Ramipril with Low-Dose Hydrochlorothiazide and Moxonidine on Blood Pressure Levels in Patients with Hypertension and Associated Diabetes Mellitus Type 2

Eligibility

Ages Eligible for Study:  40 Years   -   80 Years,  Genders Eligible for Study:  Both
Criteria

Inclusion Criteria:

essential hypertension, diabetes type 2

Exclusion Criteria:

severe cardiovasculare disease , grade 3 hypertension, secondary hypertension, abnormal liver enzyms

Location and Contact Information

Please refer to this study by ClinicalTrials.gov identifier  NCT00160160

Joachim Luszick       Joachim.Luszick@solvay.com

Canada
      Site 26, Calgary,  Canada; Recruiting
See central contact

      Site 27, Montreal,  Canada; Recruiting
See central contact

      Site 28, Vancouver,  Canada; Recruiting
See central contact

      Site 29, Winnipeg,  Canada; Recruiting
See central contact

      Site 30, Quebec,  Canada; Recruiting
See central contact

      Site 31, Thornhill,  Canada; Recruiting
See central contact

Denmark
      Site 38, Roskilde,  Denmark; Recruiting
See central contact

      Site 39, Holbaek,  Denmark; Recruiting
See central contact

      Site 40, Viborg,  Denmark; Recruiting
See central contact

France
      Site 1, Paris,  France; Recruiting
See central contact

      Site 2, Tours,  France; Recruiting
See central contact

      Site 3, Blois,  France; Recruiting
See central contact

      Site 4, Anzin,  France; Recruiting
See central contact

      Site 5, Vieux Conde,  France; Recruiting
See central contact

      Site 6, Thouars,  France; Recruiting
See central contact

      Site 7, Murs-Erigne,  France; Recruiting
See central contact

      Site 8, Segre,  France; Recruiting
See central contact

      Site 9, Saumur,  France; Recruiting
See central contact

      Site 10, Chemellier,  France; Recruiting
See central contact

      Site 11, Cholet,  France; Recruiting
See central contact

      Site 12, Saint-Pierre-Montlimard,  France; Recruiting
See central contact

      Site 13, Le Mesnil-en-Vallee,  France; Recruiting
See central contact

      Site 14, La Jubaudiere,  France; Recruiting
See central contact

      Site 15, Cholet,  France; Recruiting
See central contact

      Site 16, Cholet,  France; Recruiting
See central contact

Germany
      Site 17, Riesa,  Germany; Recruiting
See central contact

      Site 18, Lueneburg,  Germany; Recruiting
See central contact

      Site 19, Kirweiler,  Germany; Recruiting
See central contact

      Site 20, Bad Muenster,  Germany; Recruiting
See central contact

      Site 21, Lambrecht,  Germany; Recruiting
See central contact

      Site 22, Floersheim,  Germany; Recruiting
See central contact

      Site 23, Waldbrunn,  Germany; Recruiting
See central contact

      Site 24, Lutherstadt,  Germany; Recruiting
See central contact

      Site 25, Lindau,  Germany; Recruiting
See central contact

Italy
      Site 58, Padova,  Italy; Recruiting
See central contact

      Site 59, Palermo,  Italy; Recruiting
See central contact

      Site 60, Napoli,  Italy; Recruiting
See central contact

      Site 61, Pisa,  Italy; Recruiting
See central contact

      Site 62, Bologna,  Italy; Recruiting
See central contact

      Site 63, Pavia,  Italy; Recruiting
See central contact

      Site 64, Torino,  Italy; Recruiting
See central contact

Norway
      Site 41, Skedsmokorset,  Norway; Recruiting
See central contact

      Site 42, BERGEN,  Norway; Recruiting
See central contact

      Site 43, Alesund,  Norway; Recruiting
See central contact

      Site 44, Horten,  Norway; Recruiting
See central contact

Spain
      Site 51, Badalona,  Spain; Recruiting
See central contact

      Site 52, Madrid,  Spain; Recruiting
See central contact

      Site 53, Granada,  Spain; Recruiting
See central contact

      Site 54, Ciudad Real,  Spain; Recruiting
See central contact

      Site 55, Badajoz,  Spain; Recruiting
See central contact

      Site 56, Barcelona,  Spain; Recruiting
See central contact

      Site 57, Barcelona,  Spain; Recruiting
See central contact

Sweden
      Site 45, Kristianstat,  Sweden; Recruiting
See central contact

      Site 46, Helsingborg,  Sweden; Recruiting
See central contact

      Site 47, Goteburg,  Sweden; Recruiting
See central contact

      Site 48, Angelholm,  Sweden; Recruiting
See central contact

      Site 49, Stockholm,  Sweden; Recruiting
See central contact

      Site 50, MALMO,  Sweden; Recruiting
See central contact

United Kingdom
      Site 32, Oldham,  United Kingdom; Recruiting
See central contact

      Site 33, Aberdeen,  United Kingdom; Recruiting
See central contact

      Site 34, Manchester,  United Kingdom; Recruiting
See central contact

      Site 35, Rugby,  United Kingdom; Recruiting
See central contact

      Site 36, Bath,  United Kingdom; Recruiting
See central contact

      Site 37, Liverpool,  United Kingdom; Recruiting
See central contact

Study chairs or principal investigators

Global Clinical Director Solvay,  Study Director,  Solvay Pharmaceuticals   

More Information

Study ID Numbers:  S171.3.012
Last Updated:  September 11, 2005
Record first received:  September 8, 2005
ClinicalTrials.gov Identifier:  NCT00160160
Health Authority: Germany: Federal Institute for Drugs and Medicinal Devices
ClinicalTrials.gov processed this record on 2005-09-13


Source: ClinicalTrials.gov
Cache Date: September 14, 2005

Resources



[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]

Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $30 a year, a savings of 70% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

Popular Treatments

Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
Testicular Cancer Treatment
GoldBambooTM

Your Integrative Health and Wellness Resource for Enalapril and Felodipine.

November 30, 2009


Page Updated: June 1, 2005
============== Advertisement ==============
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Health Forums

Copyright © 2004-2009 - Anaconda Partners LLC - All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.